Clinical trial

PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2

NCT00199212

Study summary

ClinicalTrials.gov

PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Combination of trastuzumab and PS-341 Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-10-01

PhasePHASE1

Conditions

Carcinoma Breast Stage IVunresolved

Interventions

Combination of trastuzumab and PS-341DRUG

Sponsors & collaborators

Jules Bordet Institutelead sponsor

Mapped research locations

BrusselsBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00199212 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.